2

Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?

**Rheumatology* 2021; DOI:10.1093/rheumatology/keab598

Identification of 22 susceptibility loci associated with testicular germ cell tumors

*Nature Communications* 2021; 12:4487

BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): Protocol for a non-randomised longitudinal cohort study

*BMC Rheumatology* 2021; 5:22

The use of psoriasis biomarkers, including trajectory of clinical response, to predict clearance and remission duration to UVB phototherapy

*Journal of the European Academy of Dermatology and Venereology* 2021; DOI:10.1111/jdv.17519

Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)

*BMC Psychiatry* 2021; 21:334

SFPQ promotes an oncogenic transcriptomic state in melanoma

*Oncogene* 2021; 40:5192-5203

Innovative trial approaches in immune-mediated inflammatory diseases: Current use and future potential

*BMC Rheumatology* 2021; 5:21

Developing a predictive signature for two trial endpoints using the cross-validated risk scores method

*Biostatistics* 2021; DOI: 10.1093/biostatistics/kxaa055

Revisiting the JOQUER trial: Stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine

*Rheumatology International* 2021; 41(9):1593-1600

Ivermectin for prevention and treatment of COVID-19 infection: A systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines

*American Journal of Therapeutics* 2021; 28(4):e434-e460